To determine whether FADS1 and FADS2 contribute to ven + aza resistance, we performed the siRNA knockdown of FADS1 and FADS2 with ven + aza in MOLM-13 AML cells and measured their viability. Here, FADS2 is linked to acute myeloid leukemia.